[Inactivation and antigenicity of poliomyelitis virus type 2 (MEF-1 strain) treated with beta-propiolactone].
D006801:Humans; D011051:Poliomyelitis; D017955:Poliovirus / Q000276:immunology*; D011420:Propiolactone; D011422:Propionates / Q000494:pharmacology*
D011422:Propionates; D011420:Propiolactone
POLIOMYELITIS VIRUS/immunology; PROPIONATES/effects
Inattivazione ed antigenicità di virus poliomielitico tipo 2 (ceppo MEF-1) trattato con beta-propiolattone.